Matthew Lakelin

Vice President, Scientific Affairs & Product Development, Co-Founder • Trakcel

Dr Matthew Lakelin is a co-founder of TrakCel. Using his knowledge in handling and distribution of CGTs he has assisted with the development of the technology platform and is passionate about democratising advanced therapies. Matthew provides a technical bridge between software development and the GxP application of the system. 

Matthew holds a PhD in Pharmacology and has over 20 years of experience working in the pharmaceutical and biotechnology industry. Matthew is a TrakCel ATMP industry expert and in his role as VP of Scientific Affairs is a key spokesperson and responsible for ensuring that TrakCel solutions continue to evolve to meet industry needs. 


Also speaking

Antonin de Fougerolles

Chief Executive Officer • Evox Therapeutics

Gabriella Nilsson Hall

Senior Scientist, Cell Therapy Bioprocessing Team • AstraZeneca

Eric Halioua

President & Chief Executive Officer • PDC*Line Pharma

Event Info


Advanced Therapies Investment Summit

Find out more about the Investor Pre-Day taking place 10th September 2024.

2023 Sample Attendee List

Take a look at the sample attendee list for Advanced Therapies Europe 2023 here.